Skip to main content

Day: September 16, 2024

Fluke Corporation Launches Compact, Versatile iSee Mobile Thermal Camera for Safe and Accurate Electrical Inspection On-the-Go

High resolution iSee camera enables electricians, HVAC technicians and contractors to access thermal imaging with their smart phone, for accurate temperature measurement on the go, or in hard-to-reach places.iSee Mobile Thermal CameraiSee Mobile Thermal Camera plugs into mobile with ease and can be launched in secondsiSee Mobile Thermal Camera hardwareDesigned for electricians, HVAC technicians, contractors, and other professionals who need an easier way to capture detailed thermal images for accurate temperature readingsEverett, Washington, Sept. 16, 2024 (GLOBE NEWSWIRE) — EVERETT, Wash., September 16, 2024 — Fluke Corporation, the market leader in electronic test and measurement tools, today announced the launch of the iSee Mobile Thermal Camera, a pocket-sized, portable thermal camera with the resolution...

Continue reading

truInsights into Anxiety in Pets: Trupanion Sees Record High Year of Anxiety Claims, Offers Tips for How to Spot and Prevent

truInsights is a data focused initiative introduced by Trupanion and designed to deliver valuable health-related data and insights to pet parents, veterinarians and pet lovers alike SEATTLE, Sept. 16, 2024 (GLOBE NEWSWIRE) — Anxiety claims are on the rise, according to Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs. Looking at veterinary invoice data from over one million insured pets, Trupanion indicates that in total, and on a per pet basis, 2023 was a record high for the number of veterinary claims related to anxiety and offers tips for pet parents looking for ways to spot or prevent anxiety in their own pets. A Year of Record High Claims for Anxiety In 2023, Trupanion paid 21,180 anxiety claims, and from 2019 – 2023, on average paid about 12,178 anxiety claims per year. These...

Continue reading

Coffee Holding Co., Inc. Reports an Approximately 19% Increase in Net Sales During Third Quarter of 2024

STATEN ISLAND, New York, Sept. 16, 2024 (GLOBE NEWSWIRE) — Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company”) today announced its operating results for the fiscal quarter ended July 31, 2024: Net Sales. Net sales totaled $18,813,162 for the three months ended July 31, 2024, an increase of $3,048,797, or 19%, from $15,764,365 for the three months ended July 31, 2023. The increase in net sales was due to increased sales to new private label customers. Cost of Sales. Cost of sales for the three months ended July 31, 2024 was $14,887,098, or 79.1% of net sales, as compared to $13,315,602, or 84.5% of net sales, for the three months ended July 31, 2023, an increase of $1,571,496. Cost of sales consists primarily of the cost of green coffee and packaging materials and realized and unrealized gains or losses on hedging activity. This...

Continue reading

CarGurus Appoints Jennifer Hanson as Chief People Officer

Hanson brings more than 20 years of experience specializing in organizational design, employee engagement, and workplace culture CAMBRIDGE, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) — CarGurus (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jennifer Hanson has been appointed Chief People Officer (CPO), effective September 30, 2024. With more than 20 years of experience in human resources (HR), employee benefits, and law, Hanson will lead CarGurus’ People and Talent team in their work advancing organizational strategies, talent development, and engagement to drive business performance and continued innovation. “CarGurus employees play a key role in our mission to deliver an exceptional customer experience, and I believe Jennifer’s expertise is well-aligned...

Continue reading

T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients

Expands available market to include over 200 children’s hospitals in the United States LEXINGTON, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its FDA-cleared T2Candida® Panel for pediatric patients. The Company expects to immediately begin marketing and selling the T2Candida Panel under the expanded pediatric claim. The T2Candida Panel is the only FDA-cleared diagnostic test able to detect sepsis-causing Candida species directly-from-blood, in just 3-5 hours, without the need to wait days for a positive blood culture. The T2Candida Panel runs on the FDA-cleared T2Dx® Instrument and simultaneously...

Continue reading

Genome Editing Market to Surpass Market Valuation of USD 31.15 Billion by 2031 | SkyQuest Technology

Global Genome Editing Market size was valued at USD 8.99 billion in 2023 to USD 31.15 billion by 2031, growing at a CAGR of 16.80% during the forecast period (2024-2031). WestFord, Sept. 16, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Genome Editing Market will reach a value of USD 31.15 Billion by 2031, with a CAGR of 16.80% during the forecast period (2024-2031). Genome editing has witnessed notable progress in recent years backed by key trends, including a higher focus on therapeutic applications, the growing use of CRISPR technology, and regulatory developments. The market is facing expansion in clinical trials, wherein some are shifting towards commercialization. These trends are aiding the growth of the genome editing market. Besides, the market is also fueled by technological advancements, essentially CRISPR-Cas9...

Continue reading

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a pro forma basis Adds two durable commercial assets ILUVIEN® and YUTIQ® with significant growth potential, expanding ANI’s foothold in strategic therapeutic area of ophthalmology Anticipated to drive high single-digit to low double-digit accretion in adjusted non-GAAP EPS in 2025 and to be substantially accretive thereafter New capital structure in place, reducing interest expense by approximately $39 million on an annualized basis (1) ANI maintains its 2024 financial guidance for the standalone Company based on continued momentum across Purified Cortrophin® Gel (Cortrophin Gel) and GenericsPRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP)...

Continue reading

Dave Cantin Group Announces Biltmore Automotive Services’ Acquisition of DCG’s Capital and Ownership Accelerator Program Lines of Business

Business Units’ Move Signals DCG Focus on Advising the Top 500 Automotive Groups NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — The Dave Cantin Group, a leading mergers and acquisitions advisory company to retail automotive groups and their owners, today announced that Biltmore Automotive Services has acquired two of DCG’s lines of business: DCG Capital and its innovative Ownership Accelerator Program (OAP). The parties began negotiating the deal during the 2024 National Association of Minority Automobile Dealers (NAMAD) conference. “Biltmore is combining the DCG divisions that cater to first-time dealership buyers with its own Path to Ownership program for first-time buyers as DCG further concentrates its focus on advising the nation’s top 500 dealership groups on growth strategies, platform management, acquisitions and divestitures,”...

Continue reading

ERES REIT Declares September 2024 Monthly Distribution

TORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the September 2024 monthly cash distribution of €0.01 per Unit and Class B LP Unit (the “September Distribution”), being equivalent to €0.12 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the “Unitholders”) of record on September 30, 2024, with payment on October 15, 2024. The Euro-denominated distribution will be paid in Canadian dollars based on the exchange rate on the date of payment (estimated C$0.01501 per Unit and Class B LP Unit). Registered Unitholders will be provided with an option to elect to receive such distribution in Euros rather than Canadian dollars. If no such election is made, registered...

Continue reading

Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)

Pathfinder’s capabilities are now available via the cloud, giving law enforcement new deployment options to accelerate justice TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) — Cellebrite (Nasdaq: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today Pathfinder in the Cloud with Amazon Web Services (AWS) (Nasdaq: AMZN), allowing customers to access Cellebrite’s industry-leading investigative analytics solution, Pathfinder, through the secure Amazon Virtual Private Cloud (VPC). Now available for on-premises and cloud use, Pathfinder drastically reduces the hours investigators and analysts spend on cases because its artificial intelligence (AI) capabilities help to swiftly identify meaningful data and connections across multiple devices. It...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.